Laurens Raes

Laurens Raes is a researcher at the Nuclear Medicine department of the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, with a focus on molecular imaging, single-domain antibodies, and radiopharmaceutical applications. His work bridges nuclear medicine with virtual reality and advanced dose optimization strategies.

Research Interests: His research spans HER2-positive breast cancer imaging, alpha-emitting radiopharmaceuticals (e.g., At-211), and virtual reality integration in medical imaging. He has published extensively on PET/CT and SPECT methodologies, including reconstruction algorithms and fluorophore development.

Scientific Contributions:

• 2024: Developed frameworks for radiopharmaceutical therapy dose reporting (Kiess et al., Journal of Clinical Oncology).
• 2024: Optimized blood pool SPECT protocols for clinical efficiency (Raes, European Journal of Nuclear Medicine).
• 2023: Investigated VR headset effects on PET/CT quality and fluorescence lifetime imaging for tumor detection.

Awards:

• 2024: ARCANE fellowship for computer-aided neurodegenerative disease evaluation.
• 2024: Henry H. Wagner, Jr. Symposium highlight for alpha-emitter research.

Activities: Active in conferences (e.g., Alphavision 2025, International Workshop on Alpha Nuclides 2024) and collaborative projects like ARCANE 2025-2028, integrating AI with neuroimaging workflows.